Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Oct 7;186(14):E547-56.
doi: 10.1503/cmaj.140495. Epub 2014 Sep 2.

Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial

Annemarieke de Jonghe  1 , Barbara C van Munster  2 , J Carel Goslings  2 , Peter Kloen  2 , Carolien van Rees  2 , Reinder Wolvius  2 , Romuald van Velde  2 , Marcel Levi  2 , Rob J de Haan  2 , Sophia E de Rooij  2 ; Amsterdam Delirium Study Group
Affiliations
Randomized Controlled Trial

Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial

Annemarieke de Jonghe et al. CMAJ. .

Abstract

Background: Disturbance of the sleep-wake cycle is a characteristic of delirium. In addition, changes in melatonin rhythm influence the circadian rhythm and are associated with delirium. We compared the effect of melatonin and placebo on the incidence and duration of delirium.

Methods: We performed this multicentre, double-blind, randomized controlled trial between November 2008 and May 2012 in 1 academic and 2 nonacademic hospitals. Patients aged 65 years or older who were scheduled for acute hip surgery were eligible for inclusion. Patients received melatonin 3 mg or placebo in the evening for 5 consecutive days, starting within 24 hours after admission. The primary outcome was incidence of delirium within 8 days of admission. We also monitored the duration of delirium.

Results: A total of 452 patients were randomly assigned to the 2 study groups. We subsequently excluded 74 patients for whom the primary end point could not be measured or who had delirium before the second day of the study. After these postrandomization exclusions, data for 378 patients were included in the main analysis. The overall mean age was 84 years, 238 (63.0%) of the patients lived at home before admission, and 210 (55.6%) had cognitive impairment. We observed no effect of melatonin on the incidence of delirium: 55/186 (29.6%) in the melatonin group v. 49/192 (25.5%) in the placebo group; difference 4.1 (95% confidence interval -0.05 to 13.1) percentage points. There were no between-group differences in mortality or in cognitive or functional outcomes at 3-month follow-up.

Interpretation: In this older population with hip fracture, treatment with melatonin did not reduce the incidence of delirium.

Trial registration: Netherlands Trial Registry, NTR1576: MAPLE (Melatonin Against PLacebo in Elderly patients) study; www.trialregister.nl/trialreg/admin/rctview.asp?TC=1576.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Enrolment, randomization and follow-up of patients. Of the 850 patients assessed for eligibility, 748 met the inclusion criteria and were invited to participate, and 452 (60.4%) of these provided consent and were randomly assigned to a treatment group. *This patient was included in the analysis. †Patients with delirium at the time of admission were excluded because the primary outcome could not be measured.
Figure 2:
Figure 2:
Duration of delirium for patients receiving melatonin or placebo.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Witlox J, Eurelings LS, de Jonghe JF, et al. . Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 2010;304:443–51 - PubMed
    1. Saczynski JS, Marcantonio ER, Quach L, et al. . Cognitive trajectories after postoperative delirium. N Engl J Med 2012;367:30–9 - PMC - PubMed
    1. O’Mahony R, Murthy L, Akunne A, et al. . Synopsis of the National Institute for Health and Clinical Excellence guideline for prevention of delirium. Ann Intern Med 2011;154:746–51 - PubMed
    1. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. . Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005; 53:1658–66 - PubMed
    1. Ballard C, Hanney ML, Theodoulou M, et al. . The dementia anti-psychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009;8:151–7 - PubMed

Publication types